- 1) Walker, N. I., Bennett, R. E., and Kerr, J. F., Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat., 185, 19–32 (1989).
- 2) Quarrie, L. H., Addey, C. V., and Wilde, C. J., Apoptosis in lactating and involuting mouse mammary tissue demonstrated by nick-end DNA labelling. Cell Tissue Res., 281, 413–419 (1995).
- 3) Strange, R., Li, F., Saurer, S., Burkhardt, A., and Friis, R. R., Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development, 115, 49–58 (1992).
- 4) Ha, S. H., Lee, S. R., Lee, T. H., Kim, Y. M., Baik, M. G., and Choi, Y. J., The expression of Bok is regulated by serum in HC11 mammary epithelial cells. Mol. Cells, 12, 368–371 (2001).
- 5) Jung, D. J., Bong, J. J., and Baik, M., Extracellular proteinase inhibitor-accelerated apoptosis is associated with B cell activating factor in mammary epithelial cells. Exp. Cell Res., 292, 115–122 (2004).
- 6) Lee, M., Hwang, I., Choi, Y., Paik, S., Lee, H. B., and Baik, M., EGF inhibits expression of WDNM1 and sulfated glycoprotein-2 genes in mammary epithelial cells. Biochem. Biophys. Res. Commun., 240, 104–107 (1997).
- 7) Lee, M., Kim, H., Jeon, D., Hwang, I., Choi, B., Myung, K., Kim, H., Choi, Y., Paik, S., and Baik, M., Iron metabolism-related genes and mitochondrial genes are induced during involution of mouse mammary gland. Biochem. Biophys. Res. Commun., 224, 164–168 (1996).
- 8) McAdam, K. P., Elin, R. J., Sipe, J. D., and Wolff, S. M., Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J. Clin. Invest., 61, 390–394 (1978).
- 9) Whitehead, A. S., de Beer, M. C., Steel, D. M., Rits, M., Lelias, J. M., Lane, W. S., and de Beer, F. C., Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J. Biol. Chem., 267, 3862–3867 (1992).
- 10) Meek, R. L., Urieli-Shoval, S., and Benditt, E. P., Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA, 91, 3186–3190 (1994).
- 11) Urieli-Shoval, S., Cohen, P., Eisenberg, S., and Matzner, Y., Widespread expression of serum amyloid A in histologically normal human tissues: predominant localization to the epithelium. J. Histochem. Cytochem., 46, 1377–1384 (1998).
- 12) Urieli-Shoval, S., Meek, R. L., Hanson, R. H., Eriksen, N., and Benditt, E. P., Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am. J. Pathol., 145, 650–660 (1994).
- 13) Benditt, E. P., and Meek, R. L., Expression of the third member of the serum amyloid A gene family in mouse adipocytes. J. Exp. Med., 169, 1841–1846 (1989).
- 14) Meek, R. L., and Benditt, E. P., Amyloid A gene family expression in different mouse tissues. J. Exp. Med., 164, 2006–2017 (1986).
- 15) Meek, R. L., Eriksen, N., and Benditt, E. P., Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc. Natl. Acad. Sci. USA, 89, 7949–7952 (1992).
- 16) Ramadori, G., Sipe, J. D., and Colten, H. R., Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J. Immunol., 135, 3645–3647 (1985).
- 17) Brinckerhoff, C. E., Mitchell, T. I., Karmilowicz, M. J., Kluve-Beckerman, B., and Benson, M. D., Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins. Science, 243, 655–657 (1989).
- 18) Kisilevsky, R., and Subrahmanyan, L., Serum amyloid A changes high density lipoprotein’s cellular affinity: a clue to serum amyloid A’s principal function. Lab. Invest., 66, 778–785 (1992).
- 19) Liang, J. S., Schreiber, B. M., Salmona, M., Phillip, G., Gonnerman, W. A., de Beer, F. C., and Sipe, J. D., Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J. Lipid Res., 37, 2109–2116 (1996).
- 20) Migita, K., Kawabe, Y., Tominaga, M., Origuchi, T., Aoyagi, T., and Eguchi, K., Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab. Invest., 78, 535–539 (1998).
- 21) Mitchell, T. I., Jeffrey, J. J., Palmiter, R. D., and Brinckerhoff, C. E., The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim. Biophys. Acta, 1156, 245–254 (1993).
- 22) Peristeris, P., Gaspar, A., Gros, P., Laurent, P., Bernon, H., and Bienvenu, J., Effects of serum amyloid A protein on lymphocytes, HeLa, and MRC5 cells in culture. Biochem. Cell Biol., 67, 365–370 (1989).
- 23) Shainkin-Kestenbaum, R., Zimlichman, S., Lis, M., Lidor, C., Pomerantz, M., Knyszynski, A., Preciado-Patt, L., and Fridkin, M., Effect of serum amyloid A, an HDL-apolipoprotein, on endothelial cell proliferation: implication of an enigmatic protein in atherosclerosis. Biomed. Pept. Proteins Nucleic Acids, 2, 79–84 (1996).
- 24) Steinmetz, A., Hocke, G., Saile, R., Puchois, P., and Fruchart, J. C., Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim. Biophys. Acta, 1006, 173–178 (1989).
- 25) Mantovani, A., The interplay between primary and secondary cytokines: cytokines involved in the regulation of monocyte recruitment. Drugs, 54 (Suppl 1), 15–23 (1997).
- 26) Castell, J. V., Andus, T., Kunz, D., and Heinrich, P. C., Interleukin-6: the major regulator of acute-phase protein synthesis in man and rat. Ann. NY Acad. Sci., 557, 87–99; discussion 100–101 (1989).
- 27) You, S., Kim, H., El Halawani, M. E., and Foster, D. N., Three different turkey luteinizing hormone receptor (tLH-R) isoforms. II. Characterization of differentially regulated tLH-R messenger ribonucleic acid isoforms in the ovary. Biol. Reprod., 62, 117–124 (2000).
- 28) You, S., Kim, H., Hsu, C. C., El Halawani, M. E., and Foster, D. N., Three different turkey luteinizing hormone receptor (tLH-R) isoforms. I. Characterization of alternatively spliced tLH-R isoforms and their regulated expression in diverse tissues. Biol. Reprod., 62, 108–116 (2000).
- 29) Herrmann, M., Lorenz, H. M., Voll, R., Grunke, M., Woith, W., and Kalden, J. R., A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res., 22, 5506–5507 (1994).
- 30) Meek, R. L., Eriksen, N., and Benditt, E. P., Serum amyloid A in the mouse: sites of uptake and mRNA expression. Am. J. Pathol., 135, 411–419 (1989).
- 31) Inada, H., Izawa, I., Nishizawa, M., Fujita, E., Kiyono, T., Takahashi, T., Momoi, T., and Inagaki, M., Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. J. Cell Biol., 155, 415–426 (2001).
- 32) Bouker, K. B., Skaar, T. C., Riggins, R. B., Harburger, D. S., Fernandez, D. R., Zwart, A., Wang, A., and Clarke, R., Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis, 26, 1527–1535 (2005).
- 33) Gillmore, J. D., Lovat, L. B., Persey, M. R., Pepys, M. B., and Hawkins, P. N., Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet, 358, 24–29 (2001).
- 34) Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M., Kelsey, S. F., Shaw, L. J., Pepine, C. J., Sharaf, B., Bairey Merz, C. N., Sopko, G., Olson, M. B., and Reis, S. E., Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation, 109, 726–732 (2004).
- 35) Uhlar, C. M., and Whitehead, A. S., Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem., 265, 501–523 (1999).
- 36) Banner, D. W., D’Arcy, A., Janes, W., Gentz, R., Schoenfeld, H. J., Broger, C., Loetscher, H., and Lesslauer, W., Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell, 73, 431–445 (1993).
- 37) Betts, J. C., Cheshire, J. K., Akira, S., Kishimoto, T., and Woo, P., The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J. Biol. Chem., 268, 25624–25631 (1993).
- 38) Hagihara, K., Nishikawa, T., Sugamata, Y., Song, J., Isobe, T., Taga, T., and Yoshizaki, K., Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells, 10, 1051–1063 (2005).
- 39) Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V., TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84, 299–308 (1996).
- 40) Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., and Leder, P., The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity, 8, 297–303 (1998).
- 41) Yeh, W. C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L., Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D. V., and Mak, T. W., Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity, 7, 715–725 (1997).
- 42) Abbadie, C., Kabrun, N., Bouali, F., Smardova, J., Stehelin, D., Vandenbunder, B., and Enrietto, P. J., High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell, 75, 899–912 (1993).
- 43) Thorn, C. F., and Whitehead, A. S., Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2. J. Immunol., 169, 399–406 (2002).
- 44) Larson, M. A., Wei, S. H., Weber, A., Weber, A. T., and McDonald, T. L., Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide. Biochem. Biophys. Res. Commun., 301, 1030–1037 (2003).
- 45) Wang, C. Y., Mayo, M. W., and Baldwin, A. S., Jr., TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science, 274, 784–787 (1996).
- 46) Marti, A., Lazar, H., Ritter, P., and Jaggi, R., Transcription factor activities and gene expression during mouse mammary gland involution. J. Mammary Gland Biol. Neoplasia, 4, 145–152 (1999).
- 47) Bing, Z., Huang, J. H., and Liao, W. S., NFkappa B interacts with serum amyloid A3 enhancer factor to synergistically activate mouse serum amyloid A3 gene transcription. J. Biol. Chem., 275, 31616–31623 (2000).
- 48) Fleischman, D. A., and Gabrieli, J., Long-term memory in Alzheimer’s disease. Curr. Opin. Neurobiol., 9, 240–244 (1999).
- 49) Boatright, K. M., and Salvesen, G. S., Mechanisms of caspase activation. Curr. Opin. Cell Biol., 15, 725–731 (2003).
- 50) Strasser, A., O’Connor, L., and Dixit, V. M., Apoptosis signaling. Annu. Rev. Biochem., 69, 217–245 (2000).
Full access
Induction of Serum Amyloid A Genes Is Associated with Growth and Apoptosis of HC11 Mammary Epithelial Cells
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.